IL6 and metabolic syndrome: Recent studies also showed that dyslipidemia was related to higher levels of inflammatory markers, such as interleukin-6 (IL-6), tumor necrosis factor alpha-a (TNF-α), and C-reactive protein (CRP) [36–38].